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Abstract
In contrast to the classical “one size fits all” approach, precision medicine pro-
poses the customization of individualized treatment regimes to account for patients’
heterogeneity in response to treatments. Most of existing works in the literature fo-
cused on estimating optimal individualized treatment regimes. However, there has
been less attention devoted to hypothesis testing regarding the existence of overall
qualitative treatment effects, especially when there is a large number of prognostic
covariates. When covariates don’t have qualitative treatment effects, the optimal
treatment regime will assign the same treatment to all patients regardless of their
covariate values. In this paper, we consider testing the overall qualitative treatment
effects of patients’ prognostic covariates in a high dimensional setting. We propose
a sample splitting method to construct the test statistic, based on a nonparametric
estimator of the contrast function. When the dimension of covariates is large, we con-
struct the test based on sparse random projections of covariates into a low-dimensional
space. We prove the consistency of our test statistic. In the regular cases, we show
the asymptotic power function of our test statistic is asymptotically the same as the
“oracle” test statistic which is constructed based on the “optimal” projection matrix.
Simulation studies and real data applications validate our theoretical findings.
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1 Introduction
In many medical studies, patients may differ significantly in the way they respond to the
treatment. In contrast to the classical “one size fits all” approach, precision medicine pro-
poses the customization of individualized treatment regimes to account for patients’ het-
erogeneity in response to treatments. Formally speaking, a treatment regime is a function
from patients’ prognostic covariates to available treatment options. The optimal individ-
ualized treatment regime (OITR) is the one that maximizes patients’ expected responses
among all treatment regimes.
There have been increasing interests in estimating the OITR. Some common meth-
ods include Q-learning (Watkins and Dayan, 1992; Chakraborty et al., 2010), A-learning
(Robins et al., 2000; Murphy, 2003) and outcome weighted learning (OWL, Zhao et al.,
2012). Qian and Murphy (2011) considered a two-step procedure to construct the OITR.
Their method first estimates the conditional mean of the response with l1 penalty function
and then derives the OITR from the estimated conditional mean. Zhang et al. (2012)
proposed a robust method for estimating the OITR by maximizing the estimated average
response of patients (i.e, the value function). Zhang et al. (2015) proposed to use decision
lists to construct interpretable and parsimonious treatment regimes. Despite the popularity
of estimating the OITR, there is scarce work in the literature for hypothesis testing regard-
ing OITR. All these estimation methods implicitly assume that patients’ covariates have
qualitative interactions with treatment, which means that there exists a subset of patients
whose “best” treatments assigned according to the OITR are different from others.
We consider testing the existence of OITR due to the following reasons. First, the OITR
may not always exist in practice, see the data from the Nefazodone-CBASP clinical trial
study in Section 5 for an example. In this case, one treatment is better than the other for all
patients and there is no need of estimating the OITR. Second, we note that implementing
the OITR requires future patients’ covariates which can be expensive to collect in some cases
(Baker et al., 2009; Gail, 2009; Huang et al., 2015). In these cases, we recommend to adopt
the “one-size-fits-all” paradigm when the null hypothesis of no OITR is not rejected. Third,
our test is constructed based on estimated value functions’ difference comparing the OITR
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and a fixed regime (i.e. assign all to the best treatment). The test is not significant implies
that the value functions’ difference is not significant. Under such a situation, although
we can still estimate the OITR, the gain of the obtained OITR over the fixed regime in
terms of the improvement of value is not significant. Thus, the obtained OITR under such
a situation may not be of practical interest. Therefore, it is essential to test the overall
qualitative treatment effects of the prognostic covariates to determine whether we need to
implement the OITR for future patients. Gunter et al. (2011) developed an S-score to
quantify the magnitude of the marginal qualitative treatment effects of a single covariate.
However, the S-score doesn’t characterize the overall qualitative treatment effects of all
covariates. Besides, no theoretical guarantees were provided for the S-score.
For binary treatments, testing qualitative treatment effects is equivalent to testing
whether the interaction between treatment and covariates (i.e, the contrast function) is
almost surely positive or negative. To test such hypothesis, Chang et al. (2015) proposed
a test based on a L1-type functional of kernel smoothing estimators of conditional treat-
ment effects. Hsu (2017) proposed a Kolmogorov-Smirnov type test statistic based on
nonparametric estimation of conditional treatment effects with a hypercube kernel. It is
well known that kernel smoothing estimators are undesirable in practice due to the curse
of dimensionality. As a result, these test statistics are not reliable when the dimension of
the covariates is relatively large. However, in modern biomedical applications, it is likely to
obtain a large number of prognostic factors for each individual patient. To the best of our
knowledge, there are lack of methods for testing the overall qualitative treatment effects in
high-dimensional settings.
In this paper, we aim to test the overall qualitative treatment effects in a high dimen-
sional setting. This is a very challenging task due to the curse of dimensionality. To better
illustrate this point, consider a simple situation where patients’ covariates, x, consist of p
independent Rademacher variables. Then, it is equivalent to test whether the contrast as
a function of the covariates is always positive or negative for any x ∈ {−1, 1}p. Therefore,
we need to test 2p moment inequalities even in this very simplified situation. However, for
each x ∈ {−1, 1}p, we have on average N/2P observations with covariates equal to x, where
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N is the total number of observations. When N = O(2p), this seems impossible without
additional assumptions. We show in Lemma 3.1 that covariates have the overall qualita-
tive treatment effects if and only if the value function under the OITR is strictly larger
than those under fixed treatment regimes. This motivates us to construct test statistics
based on the difference between the optimal value function and the value function under
fixed treatment regimes. However, inference for such value difference is extremely difficult
in the nonregular cases, that is, there is a positive probability that the contrast function
is equal to zero. We use a sample-splitting method to construct the test statistic, based
on a nonparametric estimator of the contrast function. As long as the estimated contrast
function satisfies certain convergence rates, we show our test statistic is consistent.
When the dimension of covariates is large, we construct the test based on sparse random
projections of covariates into a low-dimensional space. Random projections have been a
powerful method for dimension reduction in the computer science literature. The key idea
behind is given in the Johnson-Lindenstrauss Lemma (Johnson and Lindenstrauss, 1984),
which states that a set of high dimensional vectors can be projected into a suitable lower-
dimensional space while approximately preserve their pairwise distances. In the statistics
literature, Lopes et al. (2011) proposed a high-dimensional two-sample test which integrates
a random projection with the Hotelling T 2 statistic. Recently, Cannings and Samworth
(2015) proposed a random projection-based method for the high-dimensional classification.
In this paper, we propose the use of random projections with sparse matrix. In contrast
to the dense sketching matrix used in Lopes et al. (2011) and Cannings and Samworth
(2015), only a small proportion of elements in the sparse sketching matrix are nonzero.
References on sparse random projections include Omidiran and Wainwright (2010); Li
et al. (2006); Nelson and Nguyeˆn (2013). In our simulation studies, we show that our
sparse random projection-based test statistics are more powerful compared to those based
on dense random projection matrix, when the OITR is “sparse”. Besides, we advocate
using data-dependent algorithms to generate sparse sketching matrix, since most random
projections will be weakly correlated with the contrast function. In theory, we prove the
consistency of our sparse random projection-based test. Moreover, in the regular cases, we
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show that the power function of our test statistic is asymptotically the same as the “oracle”
test statistic which is constructed based on the “optimal” projection matrix.
The rest of the paper is organized as follows. In Section 2, we present the definition of
the overall qualitative treatment effects. In Section 3, we introduce our test statistic and
study its asymptotic properties under the null and local alternative. Simulation studies and
real data applications are conducted in Section 4 and Section 5 respectively, to examine
the empirical performance of the proposed testing procedure. Section 6 concludes with a
summary and discussions of possible extensions.
2 Overall qualitative treatment effects
We consider a single stage study with two treatment options. Let Y be a patient’s outcome
of interest and A ∈ {0, 1} be the treatment indicator, with 0 for the standard treatment
and 1 for the new treatment. By convention, a larger value of Y indicates a better clinical
outcome. Denoted by X ∈ Rp the patient’s baseline covariates. We consider a high
dimensional setting where p is allowed to diverge with the sample size N . Let Y ∗(0)
and Y ∗(1) denote the potential outcomes of a patient that would be observed assuming
s/he received treatment 0 and 1, respectively. A treatment regime d : Rp → {0, 1} is a
deterministic function from patient’s covariate space to all possible treatment options. For
any d, we define the expected potential outcome
V (d) = E[d(X)Y ∗(1) + {1− d(X)}Y ∗(0)],
known as the value function associated with d. The optimal treatment regime dopt is defined
as the maximizer of V (d). Let τ(x) be the contrast function, i.e,
τ(x) = E(Y |A = 1, X = x)− E(Y |A = 0, X = x).
Under the following three conditions:
(A1.) Stable Unit Treatment Value Assumption (SUTVA): Y = AY ∗(0) + (1− A)Y ∗(1),
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(A2.) No unmeasured confounders: Y ∗(0), Y ∗(1) ⊥ A | X,
(A3.) Positivity: there exists some constants 0 < c1 < c2 < 1 such that 0 < c1 ≤ c2 < 1
such that c1 ≤ P (A = 1|X = x) ≤ c2 for any x,
we can show that τ(x) = E{Y ∗(1)− Y ∗(0) | X = x}. Since
V (d) = E[d(X){Y ∗(1)− Y ∗(0)}+ Y ∗(0)] = E{τ(X)d(X)}+ E{Y ∗(0)},
it is immediate to see that dopt(x) = I{τ(x) > 0}, where I(·) stands for the indicator
function.
Condition (A2) is satisfied in a randomized study, where the propensity score function
π(x) = Pr(A = 1 | X = x) is usually a known constant by design. We assume π(x) is known
throughout this Section. In Section 3.3, we allow the propensity score to be estimated from
data as in observational studies.
Covariates X are said to have the overall qualitative treatment effects (OQTE) if
Pr{τ(X) > 0} > 0 and Pr{τ(X) < 0} > 0.
In this paper, we consider testing the following hypothesis:
H0 : X dosen’t have OQTE versus H1 : X has OQTE. (1)
Assume (A1)-(A3) hold. Under H0, the optimal treatment regime assigns the same treat-
ment to all patients. Therefore, testing OQTE is equivalent to testing the existence of
OITR.
3 Proposed tests
3.1 A simple value-based test statistic in fixed p case
Assume the observed data are summarized as {Oi = (Xi, Ai, Yi), i = 1, . . . , N}, where Oi’s
are i.i.d. copies of O = (X,A, Y ). The distribution of O is allowed to vary with N . To
6
illustrate the idea, we first assume p is small and fixed, and present here a value-based
test statistic for the null hypothesis (1). Later in this section, we will consider the more
challenging high dimensional setting. Let V (0) = E{Y ∗(0)} and V (1) = E{Y ∗(1)}. The
following lemma relates OQTE to the difference between the optimal value function and
the value functions under fixed treatment regimes.
Lemma 3.1. Assume E|τ(X)| <∞, and conditions (A1)-(A3) hold. Then the followings
are equivalent: (i) X doesn’t have OQTE; (ii) V (dopt) = max{V (0), V (1)}.
By definition, we have V (dopt) ≥ max{V (0), V (1)}. Under H1, Lemma 3.1 implies
V (dopt) > max(V (0), V (1)). Therefore, it suffices to test
H0 : V (d
opt) = max{V (0), V (1)} versus H1 : V (dopt) > max{V (0), V (1)}.
For simplicity, we assume V (1) ≥ V (0). This implies that the new treatment is at least
as good as the standard one on average. The hypothesis V (1) ≥ V (0) can be tested using
historical data or data from a pilot study. When V (0) ≥ V (1), the test statistic can be
similarly constructed.
Lemma 3.1 motivates us to consider test statistics based on some estimators for the
value difference VD(dopt) = V (dopt) − V (1). For any treatment regime d, Zhang et al.
(2012) proposed an inverse propensity score weighted estimator (IPSWE) for V (d):
V̂ (d) =
1
N
N∑
i=1
[
Aid(Xi)
πi
Yi +
(1− Ai){1− d(Xi)}
1− πi Yi
]
, (2)
where πi is a shorthand for π(Xi). Plugging d ≡ 1, we obtain V̂ (1) = N−1
∑
iAiYi/πi.
For any fixed d,
√
NV̂D(d) =
√
N{V̂ (d) − V̂ (1)} corresponds to a sum of i.i.d random
variables. Therefore, its asymptotic variance can be consistently estimated by the sample
variance estimator,
σˆ2(d) =
1
N − 1
N∑
i=1
[(
1− Ai
1− πi −
Ai
πi
)
Yi{1− d(Xi)} − V̂D(d)
]2
. (3)
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Suppose τˆ(·) is an estimate of τ(·). Based on (2) and (3), it is natural to use T̂ =
√
NV̂D(dˆ)/σˆ(dˆ) as the test statistic, where dˆ(x) = I{τˆ(x) > 0}, and reject H0 when
T̂ > zα at a given significance level α, where zα stands for the upper α-th quantile of the
standard normal distribution.
Consistency of such a naive test requires E|dˆ(X) − dopt(X)|2 → 0. However, as com-
mented by Luedtke and van der Laan (2016), this assumption is typically violated in the
non-regular cases where Pr{τ(X) = 0} > 0, even when τˆ is consistent to τ . To solve this
problem, we consider a modified version of T̂ based on sample splitting and cross-validation.
Let I1 and I2 be a random partition of {1, . . . , N} into 2 disjoint subsets of equal sizes
n = N/2. For any I ⊆ {1, . . . , N} and treatment regime d, define
V̂DI(d) =
1
|I|
∑
i∈I
[(
1− Ai
1− πi −
Ai
πi
)
Yi{1− d(Xi)}
]
,
σˆ2I(d) =
1
|I| − 1
∑
i∈I
[(
1− Ai
1− πi −
Ai
πi
)
Yi{1− d(Xi)} − V̂DI(d)
]2
,
where |I| stands for the number of elements in I. Let τˆI be the corresponding estimator
of τ based on observations in I and dˆI(x) = I{τˆI(x) > 0}. We define our test statistic by
T̂CV = max
( √
nV̂DI1(dˆI2)
max{σˆI1(dˆI2), δn}
,
√
nV̂DI2(dˆI1)
max{σˆI2(dˆI1), δn}
)
, (4)
for some positive sequence δn → 0, and reject H0 when T̂CV > zα/2. The sequence δn
guarantees that the denominators in T̂CV are strictly greater than 0.
Alternative to the sample splitting method, one can consider a Wald-type test statistic
based on the online one-step estimator proposed by Luedtke and van der Laan (2016).
However, calculating such test statistic is more computationally expensive than ours.
Besides, the asymptotic normality of such test statistic requires the class of functions{
[(1−A)/{1−π(X)}−A/π(X)]Y {1− d(X)} : d
}
to be Glivenko-Cantelli, where d varies
over the range of estimators dˆ (see Section 7.3 in Luedtke and van der Laan, 2016). In
contrast, our testing procedure is valid under H0 for any dˆ.
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Theorem 3.1. Assume conditions (A1)-(A3) hold, E|Y |3 = O(1) and δn ≫ n−1/6. Then
under H0, for any 0 < α < 1, we have
lim sup
n
Pr(T̂CV > zα/2) ≤ α.
Moreover, assume that
Var
{(
A
π(X)
− 1− A
1− π(X)
)
Y {1− dˆIj(X)} | {Oi}i∈Ij
}
= op(δn), (5)
for j = 1, 2, where Var(V1 | V2) denotes the variance of V1 conditional on V2. Then, we
have Pr(T̂CV > zα/2)→ 0.
The following theorem states the consistency of our proposed test statistic. It relies on
Conditions (C1) and (C2). We provide these conditions in Section B of the Appendix to
save space.
Theorem 3.2. Assume conditions (A1)-(A3), (C1), (C2) hold, E|Y |3 = O(1) and δn → 0.
Under H1 : V (d
opt) = V (1) + hn, if hn ≫ n−1/2, then we have Pr(T̂CV > zα/2) → 1.
Moreover, assume Pr{τ(X) = 0} = 0 and lim infn σ20 > 0 where
σ20 = Var
{(
A
π(X)
− 1− A
1− π(X)
)
Y {1− dopt(X)}
}
.
If
√
nhn = O(1), then we have
Pr
(
T̂CV > zα/2
)
= 2Φ¯
(
zα
2
−
√
nhn
σ0
)
− Φ¯2
(
zα
2
−
√
nhn
σ0
)
+ o(1),
where Φ¯(z) = Pr(Z ≥ z) for a standard normal random variable Z.
Theorem 3.1 and 3.2 show the consistency of our testing procedure. Note that Con-
ditions (C1) and (C2) are not required to ensure Theorem 3.1. This suggests the type-I
error is well controlled regardless of any estimating procedure. On the other hand, condi-
tions on δn in Theorem 3.1 are stronger than those in Theorem 3.2. In the regular cases
when Pr{τ(X) = 0} = 0, Theorem 3.2 provides the asymptotic power function of our test.
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Notice that hn is equal to E[−τ(X){τ(X) < 0}] which relies on the dependence structure
of the covariates. As a result, the power of our test depends crucially on the underlying
data-generating process.
In this paper, dˆ is obtained by a plug-in estimator based on some nonparametric
estimation of the contrast function. Alternatively, one can directly estimate dopt using
OWL. Theorem 3.2 holds as long as the estimated decision function dˆ satisfies V (dˆI) =
V (dopt) + op(|I|−1/2).
Since we assume V (1) ≥ V (0), under H0, we have Pr{τ(X) ≥ 0} = 1. In the regular
cases where Pr{τ(X) = 0} = 0, we have Pr{dopt(X) = 1} = 1 and hence
Var
{(
A
π(X)
− 1− A
1− π(X)
)
Y {1− dopt(X)}
}
= 0.
Besides, in the regular cases, dopt can be consistently estimated by dˆIj (see Equation (S.18)
in the supplementary article). Assume conditions (C1) and (C2) hold with γ ≥ 1. Then
we can show (5) holds. Hence, the type-I error of our test will go to 0.
3.2 A sparse random projection-based test statistic
When p is large, it is far more challenging to estimate the contrast function τ(x) due to the
curse of dimensionality. To handle high-dimensional covariates, we project the covariate
space into a low dimensional vector space to construct our test statistic. Throughout this
paper, we assume the dimension of the projected space, q is fixed. For a given matrix
S ∈ Rq×p and any ω ∈ Rq, define
τS(ω) = E{τ(X)|SX = ω}.
Under (A1)-(A3), the treatment regime doptS (x) = I{τS(Sx) > 0} is optimal in the sense
that it maximizes the value function among the class of treatment regimes based only on
the projected covariates SX.
Since q is small, τS can be consistently estimated. We can construct a value-based
test statistic as discussed in Section 3.1 based on the projected data {OSi }i∈{1,...,N} where
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OSi = (SXi, Ai, Yi). The power of such test statistic depends crucially on the sketching
matrix S. To better understand this, consider the following example:
τ(X) =
{(
X(1) +X(2)√
2
)2
− δ
}(
X(3) +X(4) +X(5) +X(6) +X(7)√
5
)2
, (6)
for some δ > 0, where X(j) denotes the j-th element of X.
Apparently, we have τ(X) > 0 if |X(1) +X(2)| > √2δ and τ(X) < 0 if |X(1) +X(2)| <
√
2δ. Assume X ∼ N(0, Ip). Then X have the OQTE. Let q = 1, the “optimal” sketching
matrix S∗ is equal to
S∗ = c0(1, 1, 0, 0, . . . , 0),
for any c0 ̸= 0. For any S ∈ R1×p such that S∗ST = 0, SX is independent of X(1) +X(2).
Then, we have
τS(ω) = E{τ(X)|SX = ω}
= E
[∣∣∣∣∣
{(
X(1) +X(2)√
2
)2
− δ
}(
X(3) +X(4) +X(5) +X(6) +X(7)√
5
)2∣∣∣∣∣SX = ω
]
= (1− δ)E
{(
X(3) +X(4) +X(5) +X(6) +X(7)√
5
)2∣∣∣∣∣SX = ω
}
.
Hence, τS(ω) is always nonnegative or nonpositive as a function of ω. As a result, the test
statistic based on {OSi }i doesn’t have any power to detect the OQTE. The challenge here
lies in finding a projection matrix S that is highly correlated with S∗.
Below, we propose a data-dependent algorithm to generate S and introduce our test
statistic. Our theory shows that our test statistic works as if the optimal sketching matrix
S∗ were known. Statistical properties of our testing procedure are formally studied in
Section 3.2.2.
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3.2.1 Test statistic
Assume for now, we have an estimator τˆSI for τ
S based on any subset of the projected
data {OSi }i∈I and an algorithm to sample sparse sketching matrices whose distribution
G(S, {Oi}i∈I) is allowed to depend on {Oi}i∈I . We describe the whole testing procedure in
Algorithm 1.
Algorithm 1. Calculate the random projection-based test statistic.
1. Input observations {Oi}i=1,...,N , δn, α and a sampling distribution G.
2. Randomly partition the data into two subsets {Oi}i∈I1 and {Oi}i∈I2 .
3. For j = 1, 2,
(i) Independently sample a sparse sketching matrix SIj ∼ G(S, {Oi}i∈Ij);
(ii) Obtain estimators τˆ
SIj
Ij
and dˆ
SIj
Ij
(x) = I{τˆSIjIj (SIjx) > 0};
(iii) Calculate T̂ SIj =
√
nV̂DIcj (dˆ
SIj
Ij
)/max{σˆIcj (dˆ
SIj
Ij
), δn}.
4. Reject H0 if T̂SRP = max(T̂
SI1 , T̂ SI2 ) > zα/2.
Now we present our algorithm for generating sparse sketching matrix. We first introduce
some notations. For any matrix Ψ with J rows, let Ψ(i) be the ith row of Ψ. For any vector
ψ ∈ RJ and any setM⊆ {1, . . . , J}, denote ψM as the subvector of ψ formed by elements
in M. Let Mc be the complement of M. Let ∥ψ∥0 be the number of nonzero elements
in ψ and ∥ψ∥2 be the Euclidean norm of ψ. Let S denote the space of sparse sketching
matrices:
S = {S ∈ Rq×p : ∥S(i)∥0 ≤ s, ∥S(i)∥2 = 1, ∀i = 1, . . . , q},
for some fixed integer s that satisfies 2 ≤ s ≤ p. Denoted by N(0, IJ) a J-dimensional
Gaussian random vector with mean zero and identity covariance matrix.
It remains to generate SIj based on the sub-dataset {Oi}i∈Ij . We first sample many
sparse sketching matrices from S. Each row of the sketching matrix is independently and
uniformly distributed on the space {S ∈ Rp : ∥S∥0 = s, ∥S∥2 = 1}. This corresponds to
Step 2 in our proposed algorithm below. Then we output the sparse sketching matrix that
maximizes the estimated value difference function. Specifically, we propose using data-
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splitting strategy for evaluation of the value difference function. That is, for each sketching
matrix, we randomly divide {Oi}i∈Ij into K folds, use any of the K − 1 subsamples to
estimate the OITR based on projected covariates, use the remaining subsamples to evaluate
the corresponding value difference function, and aggregate these value difference functions
over different subsamples. This corresponds to Step 3-5 in our proposed algorithm below.
We summarize our procedure in Algorithm 2.
Algorithm 2. Generate data-dependent sparse random sketching matrix.
1. Input observations {Oi}i∈I , integers B, s, q and K ≥ 2.
2. Generate i.i.d matrices S1, S2, . . . , SB according as S0 whose distribution is
described as follows. For j = 1, . . . , q,
(i) Independently select a simple random sample Mj of size s from {1, . . . , p};
(ii) Independently generate a Gaussian random vector gj ∼ N(0, Is);
(iii) Set S
(j)
0,Mcj
= 0 and S
(j)
0,Mj
= gj/∥gj∥2.
3. Randomly divide I into K subsets {I(k)}Kk=1 of equal sizes. Let I(k)− = I ∩ (I(k))c.
4. For b = 1, . . . , B,
(i) For k = 1, . . . ,K,
(i.1) Obtain the estimator τˆSb
I(k)−
and dˆSb
I(k)−
(x) = I{τˆSb
I(k)−
(Sbx) > 0};
(i.2) Evaluate the value difference V̂DI(k)(dˆ
Sb
I(k)−
).
(ii) Obtain the cross-validated estimator V̂D
Sb
CV =
∑
k V̂DI(k)(dˆ
Sb
I(k)−
)/K.
5. Output Sbˆ, where bˆ = argmax
B
b=1 V̂D
Sb
CV .
3.2.2 Asymptotic properties under the null and local alternative
We first show the validity of the proposed test, which applies to any estimator τˆSI . For any
positive sequences {an} and {bn}, we write an ≫ bn if and only if lim supn bn/an = 0.
Theorem 3.3. Assume (A1)-(A3) hold, E|Y |3 = O(1) and δn ≫ n−1/6. Then under H0,
we have
lim sup
n
Pr
(
T̂SRP > zα/2
)
≤ α.
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Moreover, assume that
Var
{(
A
π(X)
− 1− A
1− π(X)
)
Y {1− dˆSIjIj (X)} | {Oi}i∈Ij , SIj , Ij
}
= op(δn),
for j = 1, 2. Then we have Pr(T̂SRP > zα/2)→ 0.
Let S∗ = argmaxS∈S V (d
opt
S ) be the optimal sketching matrix. The optimal sketching
matrix S∗ may not be unique. To see this, for any sketching matrix S∗ ∈ S that maximizes
V (doptS ), −S∗ also maximizes V (doptS ) and we have −S∗ ∈ S. Moreover, when q ≥ 2, there
may exist infinitely many maximizers. Denoted by S∗ the set of all maximizers. We assume
for any S∗1 , S
∗
2 ∈ S∗,
E
[
|doptS∗1 (X)− d
opt
S∗2
(X)|I{τS∗1 (S∗1X) ̸= 0, τS
∗
2 (S∗2X) ̸= 0}
]
= 0. (7)
When Pr{τS∗(S∗X) = 0} = 0 for any S∗ ∈ S∗, this implies the class of treatment regimes
{doptS∗ : S∗ ∈ S∗} will almost surely recommend the same treatment to any given patient.
Our theoretical studies are mostly concerned with the “oracle” test statistic. The oracle
knew the set S∗ ahead of time. In Algorithm 1: Step 3(i), instead of using Algorithm 2
to sample SI1 and SI2 , we use the oracle set SI1 = SI2 = S∗ for an arbitrary S∗ ∈ S∗.
Denoted by T̂oracle the resulting oracle test statistic. Let h
∗
n = argmaxS∗∈S∗ V (d
opt
S∗ )−V (1).
Similar to Theorem 3.2, under H1, if h
∗
n ≫ n−1/2, then we can show
Pr
(
T̂oracle > zα/2
)
→ 1.
Let
σ2∗ = Var
{(
A
π(X)
− 1− A
1− π(X)
)
Y {1− doptS∗ (X)}
}
.
When Pr{τS∗(S∗X) = 0} = 0 for any S∗ ∈ S∗, under Assumption (7), we can show that
σ2∗ is the same for all S
∗ ∈ S∗. Similar to Theorem 3.2, the asymptotic power of T̂oracle can
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be derived as
Pr
(
T̂oracle > zα/2
)
= 2Φ¯
(
zα
2
−
√
nh∗n
σ∗
)
− Φ¯2
(
zα
2
−
√
nh∗n
σ∗
)
+ o(1). (8)
In the following, we prove the consistency of our proposed testing procedure when using
Algorithm 2 to generate the sparse sketching matrix. Moreover, we show our test statistic
possesses the oracle property when Pr{τS∗(S∗X) = 0} = 0 for any S∗ ∈ S∗. This means
the power function of T̂SRP is asymptotically the same as the oracle test statistic T̂oracle.
Define the semimetric
dτ (S1, S2) =
√
E|τS1(S1X)− τS2(S2X)|2, ∀S1, S2 ∈ S.
For any ε > 0, we define an ε-neighborhood of S∗ with respect to dτ by
S(ε) = {S ∈ S : ∃S∗ ∈ S∗, dτ (S, S∗) ≤ ε} .
We make the following assumptions.
(A4.) For any sketching matrices S1, S2, . . . , SB ∈ S and any I ⊆ {1, 2, . . . , N} with
|I| ≥ n/2, assume the following event holds with probability tending to 1,
B
max
b=1
EX |τˆSjI (SjX)− τSj(SjX)|2 = O
(
n−r0 log n
)
,
where the expectation EX is taken with respect to X, and the little-o term is uniform in I
and S1, . . . , SB.
(A5.) Assume B ≫ (p√n)(s−1)q. In addition, assume there exist some constant C¯ > 0 and
some sketching matrix S∗ ∈ S∗ such that
dτ (S, S∗) ≤ C¯
(
q∑
j=1
∥S(j) − S∗(j)∥22
)1/2
, ∀S ∈ S. (9)
(A6.) Assume there exists some constants γ, ε0, δ0 > 0 such that for any S ∈ S(ε0),
Pr{0 < |τS(SX)| ≤ t} = O(tγ), where the big-O term is uniform in 0 < t < δ0 and S.
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(A7.) For any sufficiently small ε > 0, there exists some constant l0 > 0 such that for any
sketching matrix S satisfying V (doptS ) ≥ V (doptS∗ )− ε, we have S ∈ S(εl0).
Condition (A4) assumes the uniform convergence rate of τˆSbI for b = 1, . . . , B. Since the
uniform convergence rate increases as B increases, Condition (A4) gives the upper bound
for B. On the contrary, Condition (A5) gives the lower bound for B. It requires B to
diverge at a proper rate, to give us a good chance for finding a random projection with a
large value function. More specifically, under (A5), we can show that
Pr
{
B
max
b=1
V (doptSb ) = V (d
opt
S∗ ) + o(n
−1/2)
}
→ 1.
In Section C.3 of the Appendix, we provide an example and show Condition (9) in (A5)
holds.
Condition (A6) holds with γ = 1 when τS(SX) has a uniformly bounded density func-
tion near 0 for all S ∈ S(ε0). In Section C.4 of the Appendix, we provide some detailed
examples and show (A6) holds under these scenarios. In addition, assume τ(X) ≥ δ0
almost surely or τ(X) ≤ −δ0 almost surely. Then for any sketching matrix S, we have
τS(SX) ≥ δ0 almost surely or τS(SX) ≤ −δ0. As a result, (A6) automatically holds for
any γ > 0. Condition (A7) implies that any sketching matrix S that nearly maximizes
V (doptS ) lies in a small neighborhood of S∗ with respect to dτ . We provide some examples
and show (A7) holds with l0 = 1/2 in Section C.5 of the Appendix.
Theorem 3.4. Assume Conditions (A1)-(A5) hold, E|Y |3 = O(1), logB = o(n1/3) and
δn → 0. If h∗n ≫ max(
√
logB/
√
n, n−r0/2
√
log n), then we have
Pr
(
T̂SRP > zα/2
)
→ 1.
Moreover, assume (7), (A6), (A7) hold, Pr{τS∗(S∗X) = 0} = 0 for any S∗ ∈ S∗, √nh∗n =
O(1), B = O(nκB) for some κB > 0, r0 >
γ+2
2γ+2
and lim infn σ∗ > 0. Then we have
Pr
(
T̂SRP > zα/2
)
= 2Φ¯
(
zα
2
−
√
nh∗n
σ∗
)
− Φ¯2
(
zα
2
−
√
nh∗n
σ∗
)
+ o(1).
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Assume p = O(n) and we set B = c∗n
{3q(s−1)+ϵ}/2 for any c∗, ϵ > 0. Then the conditions
B ≫ (p√n)(s−1)q in (A5) and B = O(nκB) in Theorem 3.4 automatically hold. It is worth
mentioning that if dopt = doptS∗ almost surely for some S
∗ ∈ S∗, then we have h∗n = hn and
σ∗ = σ0 where hn and σ0 are defined in Theorem 3.2. When these quantities don’t depend
on p, Theorem 3.4 implies that the asymptotic power of our test is independent of p.
3.3 Some implementation issues
3.3.1 Doubly-robust test statistics
So far we have assumed that the propensity scores are known for all patients. In the
following, we introduce a doubly-robust test statistic to deal with data from an observa-
tional study. We begin by introducing a doubly-robust value difference estimator, which
requires the estimation of the propensity score and the conditional mean functions h0(x) =
E(Y |A = 0, X = x) and h1(x) = E(Y |A = 1, X = x). Denoted by πˆ(·), hˆ0(·) and hˆ1(·) the
corresponding estimators. Zhang et al. (2012) proposed a doubly-robust estimator for the
value function under a given treatment regime d,
V̂ dr(d) =
1
N
N∑
i=1
{(
Ai
πˆ(Xi)
di +
1− Ai
1− πˆ(Xi)(1− di)
)
Yi
−
(
Ai
πˆ(Xi)
di +
1− Ai
1− πˆ(Xi)(1− di)− 1
)
{hˆ0(Xi)(1− di) + hˆ1(Xi)di}
}
,
where di is a shorthand for d(Xi). When either the propensity score or the conditional mean
models are correctly specified, V̂ dr(d) is consistent to V (d) (Zhang et al., 2012). Based on
V̂ dr, for any I ⊂ [1, . . . , N ] and a given treatment regime d, we define our doubly-robust
value difference estimator as
V̂D
dr
I (d) =
1
|I|
∑
i∈I
{(
1− Ai
1− πˆIi
− Ai
πˆIi
)
Yi −
(
1− Ai
1− πˆIi
− 1
)
hˆI0,i +
(
Ai
πˆIi
− 1
)
hˆI1,i
}
(1− di),
where πˆIi = πˆ
I(Xi), hˆ
I
0,i = hˆ
I
0 (Xi), hˆ
I
1,i = hˆ
I
1 (Xi), and πˆ
I , hˆI0 , hˆ
I
1 are obtained based on
{Oi}I . When p is large, we recommend to estimate π, h0 and h1 via penalized regression.
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The asymptotic variance of
√|I|V̂Ddr(d) can be consistently estimated by σˆdrI (d) whose
exact form is given in Section A of the Appendix.
We briefly summarize our test procedures. Similar to Algorithm 1, we first randomly
partition the data into two halves {Oi}I1 and {Oi}I2 , and obtain the estimators πˆIj , hˆIj0 ,
hˆ
Ij
1 based on {Oi}i∈Ij for j = 1, 2. Then we independently sample the sparse sketching
matrices SI1 and SI2 . The sampling algorithm is similar to Algorithm 2. Specifically,
for j = 1, 2, we randomly divide Ij into {I(k)j }Kk=1 and independently sample S1, . . . , SB
as Steps 2 and 3 of Algorithm 2. Then we calculate the doubly-robust value difference
estimator,
V̂D
dr,Sb
CV = K
−1
∑
k
V̂D
dr
I
(k)
j
(dˆSb
I
(k)−
j
), (10)
for each Sb where I(k)−j = Ij ∩ (I(k)j )c, and set SIj = Sbˆ where bˆ = argmaxBb=1 V̂D
dr,Sb
CV .
Finally, we define our test statistic by
T̂ drSRP = max
 √nV̂DdrI2(dˆSI1I1 )
max{σˆdrI2(dˆ
SI1
I1
), δn}
,
√
nV̂D
dr
I1
(dˆ
SI2
I2
)
max{σˆdrI1(dˆ
SI2
I2
), δn}
 , (11)
and reject the test if T̂ drSRP > zα/2 for a given significance level α > 0. Statistical properties
of T̂ drSRP can be similarly established.
3.3.2 Estimation of τS
The projected contrast function τS can be estimated by any machine learning or statistical
nonparametric methods. In our implementation, we estimate τS using cubic B-splines. Let
I be an arbitrary subset of {1, . . . , N}. Based on the dataset {Oi}i∈I , we first estimate
π using the penalized logistic regression, and estimate h0, h1 using the penalized linear
regression, with SCAD penalty functions (Fan and Li, 2001). These penalized regressions
are implemented by the R package ncvreg and the tuning parameters are selected via 10-
folded cross-validation. Let πˆIi , hˆ
I
0,i and hˆ
I
1,i be the corresponding estimators for π(Xi),
h0(Xi) and h1(Xi), respectively. Recall that S
(j) ∈ R1×p is the jth row of sketching matrix
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S. We define the pseudo outcome
τˆIi =
(
Ai
πˆIi
− 1− Ai
1− πˆIi
)
Yi −
(
Ai
πˆIi
− 1
)
hˆI1,i +
(
1− Ai
1− πˆIi
− 1
)
hˆI0,i, (12)
and minimize
(ξˆI1 , · · · , ξˆIq ) = argmin
ξ1,··· ,ξq∈Rk
1
|I|
∑
i∈I
(
τˆIi −
q∑
j=1
K+4∑
k=1
NS
(j)
k (S
(j)Xi)ξj,k
)2
, (13)
where NS
(j)
1 (·), . . . , NS(j)K+4(·) are cubic B-spline bases of S(j)Xi and K is the number of in-
terior knots. Given K, we place the interior knots at equally-spaced sample quantiles of the
projected covariates {SXi}i∈I . After solving (13), we set τˆSI (Sx) =
∑q
j=1
∑K+4
k=1 N
S(j)
k (S
(j)x)ξˆIj,k.
Based on the B-spline methods, we show in Section C.2 of the Appendix (A8) holds
with r0 = 4/5 when q = 1 and B = O(n
κB) for any κB > 0. Assume (A7) holds with
γ ≥ 2/3. The condition r0 > (γ + 2)/(2γ + 2) in Theorem 3.4 is thus satisfied. More
generally, we may use series estimator (Belloni et al., 2015) to estimate τS. Then the rate
r0 in (A8) will decrease as the number of projected dimension q increases.
3.3.3 Choice of s
Our testing procedure requires specification of s, which determines the number of nonzero
elements in each row of the sketching matrix. Ideally, one could treat s as a tuning param-
eter and choose s to maximize the estimated value difference defined in (10). However, this
approach would be time-consuming. In our implementation, we set s as a discrete random
variable when sampling S1, . . . , SB. More specifically, for b = 1, . . . , B, we first indepen-
dently sample s according as some random variable s0, and then sample Sb according to
Step 3 of Algorithm 2.
We recommend to set s0 = 2 + Binom(p − 2, p0), where Binom(m, p0) is a binomial
random variable with the total number of trials equal to m and the probability of success
equal to p0. In our simulation study, we set p0 = 2/(p− 2).
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4 Simulations
4.1 Settings
We examine the finite sample performance of the proposed tests via Monte Carlo simula-
tions. Simulated data with sample size N were generated from
Y = 1 + (X(1) −X(2))/2 + Aτ(X) + e,
where X ∼ N(0, Ip), A ∼ Binom(1, 0.5) and e ∼ N(0, 0.52). Here, we set p = 50 or 100.
We consider four scenarios. In the first three scenarios, we set
τ(X) = ϕδ{(X(1) +X(2))/
√
2}(X(3) +X(4) +X(5) +X(6) +X(7))2/5,
for some function ϕδ parameterized by some δ > 0. More specifically, we set ϕδ(x) = x
2− δ
in Scenario 1, ϕδ(x) = δ cos(πx) in Scenario 2, and ϕδ(x) = δ
√
2πx in Scenario 3.
In Scenario 4, we set
τ(X) = δ

(
2∑
j=1
X(j)√
2
)2
−
(
20∑
j=3
X(j)√
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)2 (X(21) +X(22) +X(23) +X(24) +X(25))2/5.
It is immediate to see that the OITR is sparse and is a function of X(1) and X(2) in the first
three scenarios. In Scenario 4, however, a total of 20 variables are involved in the OITR.
In addition, the true OITR is linear in X under Scenario 3, but non-linear under Scenarios
1, 2 and 4. We set N = 500 in Scenarios 1, 2 and 3, and N = 1000 in Scenario 4.
For all scenarios, the parameter δ controls the degree of overall qualitative treatment
effects. Specifically, H0 holds if δ = 0 and H1 holds if δ > 0. For each scenario, we further
consider four cases by setting VD(dopt) = V (dopt)− V (1) = 0, 0.2, 0.35 and 0.5. Note that
in Scenarios 2, 3 and 4, the settings for VD(dopt) = 0 are the same. Hence, in Scenarios 3
and 4, we only report the simulation results for VD(dopt) = 0.2, 0.35 and 0.5.
We set q = 1 and calculate T̂ drSRP as described in Section 3.3. The number of interior
knots K in the cubic B-spline bases is specified in the following fashion. When generating
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SI1 or SI2 , we fix K = 3 when estimating τ
Sb for b = 1, . . . , B. After obtaining SI1 and
SI2 , K is tuned with cross-validation when estimating τ
SI1 and τSI2 . We set B = 105 for
p = 50 and B = 4× 105 for p = 100.
The whole simulation program is implemented in R. Some subroutines, including sam-
pling data-dependent sketching matrices SI1 and SI2 and estimating τ
SI1 and τSI2 , are
written in C with the GNU Scientific Library (GSL, Galassi et al., 2015).
4.2 Competing methods
Comparison is made among the following five test statistics:
(i) The proposed sparse random projection-based test statistic T̂ drSRP .
(ii) The dense random projection-based test statistic, denoted by T̂ drRP .
(iii) The cross-validated test statistic with the OITR estimated by the penalized least square
method developed in Shi et al. (2016), denoted by T̂PLS.
(iv) The cross-validated test statistic based on step-wise variable selection, denoted by T̂V S.
(v) The supremum-type test statistic T̂DL based on the desparsified Lasso estimator (??).
T̂ drRP is computed in a similar fashion as T̂
dr
SRP . We randomly partition {1, . . . , N} into
I1 ∪ I2 of equal size, generate some data dependent sketching matrices SI1 and SI2 , and
construct the test statistic as in (11). When generating SI1 or SI2 , instead of sampling
B sparse sketching matrices as described in Step 3 of Algorithm 2, we generate B dense
sketching matrices S1, . . . , SB according to Z0/∥Z0∥2, where Z0 ∈ Rp is a Gaussian random
vector with mean zero and identity covariance matrix, and set SI1 or SI2 to be the one
that gives the largest cross-validated value difference as in (10). Similar to T̂ drSRP , we set
B = 105 for p = 50 and set B = 4 × 105 for p = 100, and use cubic B-splines to estimate
τS for any sketching matrix S.
To calculate T̂PLS, we first partition the data into two halves {Oi}i∈I1 and {Oi}i∈I2 .
Then for j = 1, 2, we set dˆIj(x) = I(x¯
T βˆIj > 0) where x¯ = (1, xT )T , βˆIj is computed by
βˆIj = argmin
β∈Rp+1
∑
i∈Ij
1
|Ij|
(
Yi − X¯Ti θˆIj − (Ai − πˆIji )X¯Ti β
)2
+
p+1∑
j=2
pλn,1(|βj|), (14)
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for some penalty functions pλ, where X¯i = (1, X
T
i )
T , πˆ
Ij
i is the estimated propensity score
for the ith patient based on a penalized logistic regression with SCAD penalty function,
and θˆIj is calculated by
θˆIj = argmin
θ∈Rp+1
∑
i∈Ij
1
|Ij|(Yi − X¯
T
i θ)
2 +
p+1∑
j=2
pλn,2(|θj|). (15)
We use the SCAD penalty in both (14) and (15). The tuning parameters λn,1 and λn,2 were
selected via 10-folded cross-validation. Finally, define T̂PLS by
T̂PLS = max
 √nV̂DdrI2(dˆI1)
max{σˆdrI2(dˆI1), δn}
,
√
nV̂D
dr
I1
(dˆI2)
max{σˆdrI1(dˆI2), δn}
 . (16)
To compute T̂V S, we similarly split the observations into two sub-datasets {Oi}i∈I1 and
{Oi}i∈I2 . For each sub-dataset, we apply the sequential advantage selection (SAS, Fan
et al., 2016) to select variables with a qualitative interaction with the treatment. SAS
is a greedy stepwise selection procedure and uses a BIC-type criterion to choose the best
candidate subset of variables. Denoted by M̂I1 ,M̂I2 ⊆ {1, . . . , p} the corresponding sets
of selected variables. Then for each j = 1, 2, we calculate the pseudo responses τˆ
Ij
i , ∀i ∈ Ij
(see the definition in (12)) and compute
τˆIj = argmin
f∈Hj
1
n
∑
i∈Ij
{τˆIji − f(Xi,M̂Ij )}
2 + λj∥f∥2Hj ,
where λj > 0 is a tuning parameter, Hj is the reproducing kernel Hilbert space with the
reproducing kernel Kj(Xi,M̂Ij
, Xk,M̂Ij
) = exp{−∑l∈M̂Ij ηj,l(X(l)i −X(l)k )2} where X(l)i , X(l)k
denote the l-th element in Xi, Xk and ηj,l > 0, ∀l ∈ M̂Ij are tuning parameters. The
estimating procedure is implemented by the R package listdtr and the tuning parameters
are selected via leave-one-out cross validation. Then we define dˆIj(x) = I{τˆIj(xM̂Ij ) > 0}
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and set
T̂V S = max
 √nV̂DdrI2(dˆI1)
max{σˆdrI2(dˆI1), δn}
,
√
nV̂D
dr
I1
(dˆI2)
max{σˆdrI1(dˆI2), δn}
 . (17)
We set δn = log(log10(2n))/(2n)
1/6 in (11), (16) and (17), where log10 denotes the logarithm
with base 10.
T̂DL tests the overall treatment effects by fitting the following linear regression model
for the response:
E(Y |A,X) ≈ β0 +XTβx + Aβa + AXTβax.
Based on this model, testing the overall treatment effects is equivalent to test H∗0 : βax = 0.
Denoted by β = (β0, β
T
x , βa, β
T
ax)
T . To deal with high dimensionality, we estimate β by the
desparsified Lasso estimator β̂DL and test H∗0 based on the following supremum-type test
statistic, maxj∈Max
√
n|β̂DLj |, whereMax = {p+3, . . . , 2p+2} and β̂DLj is the j-th element
of β̂DL. The critical value of T̂DL is approximated via bootstrap. Detailed implementation
of the test can be found in Zhang and Cheng (2017).
4.3 Results
We conduct 500 simulations for each setting and report the proportions of rejecting the
null hypothesis (%) in Table 1 and Table 2, with standard errors in parenthesis (%). Under
H0, the type-I errors of our test statistic is well controlled. Specifically, in Scenario 1 when
VD = 0, the rejection probability of T̂ drSRP is exactly zero. This is in line with our theory
which suggests that the type-I error of our test statistics will converge to 0 in the regular
cases where Pr{τ(X) = 0} = 0. In Scenario 2 when VD = 0, the rejection probability of
T̂ drSRP is close to the nominal level.
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Table 1: Rejection probabilities (%) of the sparse random projection-based test, dense random projection-
based test, penalized least square-based test, step-wise selection-based test and the supremum-type test
based on the desparsified Lasso estimator, with standard errors in parenthesis (%), under Scenarios 1 and
2 where X ∼ N(0, Ip).
Scenario 1 VD = 0 VD = 20% VD = 35% VD = 50%
α level α level α level α level
p 0.01 0.05 0.01 0.05 0.01 0.05 0.01 0.05
T̂ drSRP
50 0(0) 0(0) 24(1.9) 39.6(2.2) 71(2.0) 81(1.8) 90.8(1.3) 95.2(1.0)
100 0(0) 0(0) 17.4(1.7) 29.6(2.0) 60.8(2.2) 73.8(2.0) 86.6(1.5) 92.4(1.2)
T̂ drRP
50 0(0) 0(0) 0.2(0.2) 0.6(0.4) 0.8(0.4) 3.2(0.8) 7.2(1.2) 18.6(1.7)
100 0(0) 0(0) 0.4(0.3) 0.4(0.3) 0.4(0.3) 4(0.9) 6.8(1.1) 19(1.8)
T̂PLS
50 0(0) 0(0) 0(0) 0(0) 0.4(0.3) 0.8(0.4) 6(1.1) 17.6(1.7)
100 0(0) 0(0) 0(0) 0(0) 0.8(0.4) 2.4(0.7) 8.6(1.3) 19.8(1.8)
T̂V S
50 0(0) 0(0) 1.2(0.5) 3.8(0.9) 16 (1.6) 29.4 (2.0) 36.6(2.2) 50.8(2.2)
100 0(0) 0(0) 0(0) 0.6(0.3) 8.4 (1.2) 17.4 (1.7) 23.8(1.9) 36.4(2.2)
T̂DL
50 10.2(1.4) 22.4(1.9) 11.2(1.4) 22.8(1.9) 10.8 (1.4) 21.8 (1.9) 9.8(1.3) 22.4(1.9)
100 7.6(1.2) 20.0(1.8) 7.8(1.2) 21.4(1.8) 7.6 (1.2) 22.0 (1.9) 6.8(1.1) 21.6(1.8)
Scenario 2 VD = 0 VD = 20% VD = 35% VD = 50%
α level α level α level α level
p 0.01 0.05 0.01 0.05 0.01 0.05 0.01 0.05
T̂ drSRP
50 1.2(0.5) 5.4(1) 24(1.9) 35.8(2.1) 76.4(1.9) 84.6(1.6) 90.2(1.3) 94(1.1)
100 0.6(0.3) 5.2(1) 15.2(1.6) 28.2(2) 67(2.1) 78.8(1.8) 84.2(1.6) 90.4(1.3)
T̂ drRP
50 1.8(0.6) 4.6(0.9) 2(0.6) 4.8(1) 1.6(0.6) 5.4(1) 1(0.4) 6(1.1)
100 1.2(0.5) 4.2(0.9) 1.2(0.5) 5.4(1) 0.6(0.3) 4.8(1) 0.8(0.4) 4.4(0.9)
T̂PLS
50 1.8(0.6) 6(1.1) 1.2(0.5) 4.4(0.9) 1(0.4) 4.2(0.9) 0.8(0.4) 3.8(0.9)
100 1.2(0.5) 4.2(0.9) 0.8(0.4) 4.6(0.9) 0.6(0.3) 5.6(1) 0.6(0.3) 5(1)
T̂V S
50 1.2(0.5) 6.4(1.1) 0.6(0.3) 4(0.9) 1(0.4) 6.6(1.1) 1(0.4) 5(1)
100 1.4(0.5) 5(1.0) 1.0(0.4) 5(1.0) 1.4(0.5) 6.4(1.1) 0.6(0.3) 4.6(0.9)
T̂DL
50 1.6(0.6) 6.4(1.1) 2.8(0.7) 11.8(1.4) 4.4 (0.9) 15.4 (1.6) 5.4 (1.0) 17(1.7)
100 1.2(0.5) 3.6(0.8) 2.8(0.7) 11.8(1.4) 5.2(1.0) 17.6(1.7) 7.2(1.2) 19.8(1.8)
Table 2: Rejection probabilities (%) of the sparse random projection-based test, dense random projection-
based test, penalized least square-based test, step-wise selection-based test and the supremum-type test
based on the desparsified Lasso estimator, with standard errors in parenthesis (%), under Scenarios 3 and
4 where X ∼ N(0, Ip).
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Scenario 3 VD = 20% VD = 35% VD = 50%
α level α level α level
p 0.01 0.05 0.01 0.05 0.01 0.05
T̂ drSRP
50 47.2(2.2) 71.8(2) 92.4(1.2) 97.8(0.7) 99(0.4) 100(0)
100 42.4(2.2) 61.2(2.2) 89.8(1.4) 96.2(0.9) 97.2(0.7) 99.4(0.3)
T̂ drRP
50 4.4(0.9) 16.2(1.6) 13.4(1.5) 35.8(2.1) 22(1.9) 49.4(2.2)
100 3(0.8) 8.4(1.2) 4(0.9) 14.2(1.6) 5.4(1) 19.6(1.8)
T̂PLS
50 76.4(1.9) 92(1.2) 97.8(0.7) 99.4(0.3) 99.4(0.3) 100(0)
100 64.8(2.1) 87(1.5) 97(0.8) 99.4(0.3) 98.6(0.5) 99.8(0.2)
T̂V S
50 55.6(2.2) 81.8(1.7) 93(1.1) 99(0.4) 97.8(0.7) 100(0)
100 49.8(2.2) 74.2(2.0) 90(1.3) 98.6(0.5) 99(0.4) 100(0)
T̂DL
50 99.8(0.7) 100(0) 100(0) 100(0) 100(0) 100(0)
100 99.2(0.4) 100(0) 100(0) 100(0) 100(0) 100(0)
Scenario 4 VD = 20% VD = 35% VD = 50%
α level α level α level
p 0.01 0.05 0.01 0.05 0.01 0.05
T̂ drSRP
50 22.4(1.9) 41.8(2.2) 60.4(2.2) 76.6(1.9) 72.4(2) 87.2(1.5)
100 15.2(1.6) 28(2) 49.6(2.2) 70.2(2) 70(2) 84(1.6)
T̂ drRP
50 0.4(0.3) 6.2(1.1) 0.6(0.3) 5.4(1) 0.2(0.2) 5.4(1)
100 1.2(0.5) 6(1.1) 0.8(0.4) 3.8(0.9) 1.2(0.5) 5.2(1)
T̂ drPLS
50 1.2(0.5) 5.4(1) 1.2(0.5) 6(1.1) 1.4(0.5) 4.8(1)
100 1.6(0.6) 5.8(1) 1.8(0.6) 6(1.1) 1.4(0.5) 5.2(1)
T̂ drV S
50 10.4(1.4) 24.2(1.9) 13.6(1.5) 30.6(2.1) 13.2(1.5) 29.4(2)
100 5(1) 15.6(1.6) 4.6(0.9) 20(1.8) 8.2(1.2) 18.4(1.7)
T̂ drDL
50 4.2(0.9) 11.4(1.4) 5.4(1) 14.2(1.6) 6.4(1.1) 15.8(1.6)
100 6.2(1.1) 16(1.6) 6.4(1.1) 18.2(1.7) 6.8(1.1) 19.6(1.8)
Under H1, we can see that our test statistic is much more powerful compared to other
competing test statistics in Scenarios 1, 2 and 4. For example, when VD = 0.35 and
α = 0.05, the rejection probabilities of our test are around 75% in Scenario 1. On the
other hand, T̂ drRP , T̂PLS and T̂V S fail in Scenario 2. Specifically, the rejection probabilities
of these three tests are no more than 6% in all settings. The rejection probabilities of T̂DL
are around 10%-20% in Scenario 2 under H1. However, T̂DL doesn’t have valid type-I error
rates under H0. Here, the test statistics T̂PLS and T̂DL fail mainly due to the fact that the
true OITR is not linear, while T̂ drRP and T̂V S fail partly because the dense projection and
greedy stepwise variable selection cannot correctly identify the variables with qualitative
interactions.
In Scenario 3, T̂DL and T̂PLS achieve the greatest power in all settings as expected since
the true OITR is linear in this scenario. Notice that X(1), X(2), · · · , X(7) are independent.
Although the contrast function is not linear, the estimated contrast functions via the pe-
nalized least squares (see (14) and (15)) will converge to E{τ(X)|X(1), X(2)}. As a result,
the estimated OITR is consistent. When VD = 0.35 and 0.5, the rejection probabilities of
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T̂ drSRP are slightly smaller when compared to T̂PLS, T̂DL and T̂V S, but are much larger than
those of T̂ drRP .
In Section E of the supplementary article, we report the rejection probabilities of T̂ drSRP ,
T̂ drRP , T̂PLS, T̂V S and T̂DL under the scenario where X ∼ N(0, {0.5|i−j|}i,j=1,...,p). Results
are similar to those presented in Table 1 and 2.
5 Real data
We apply our proposed test to the data from the Nefazodone-CBASP clinical trial study
(Keller et al., 2000), which enrolled 681 patients with nonpsychotic chronic major depres-
sive disorder (MDD). Patients were randomized to three treatments, including Nafazodone
(coded as 0), Cognitive Behavioral-Analysis System of Psychotherapy (CBASP, coded as
1), and the combination of Nefazodone and CBASP (2). The outcome of interests were
patients’ scores on the 24-item Hamilton Rating Scale for Depression (HRSD). The max-
imum value of HRSD was 43 and we set Y = 43 − HRSD as our response. Larger value
of Y indicates better clinical outcome. Similarly as in Zhao et al. (2012), we use a subset
of 647 patients that have complete records of 50 baseline covariates for analysis. Among
them, 216 were treated with Nafazodone, 220 with CBASP and 211 with the combination.
Our objective was to test whether the baseline covariates X have overall qualitative
treatment effects. This is equivalent to test H0 : V (d
opt) = max{V (0), V (1), V (2)}, where
V (dopt) is the optimal value function, and V (j) denotes the value function under the fixed
treatment regimes by assigning all patients to treatment j, for j = 0, 1, 2. Patients’ average
responses under treatment 0, 1, 2 are 27.14, 27.27 and 32.13, respectively. Besides, pairwise
t tests show that V (2) is significantly larger than V (0) and V (1). Therefore, it suffices to
test H0 : V (d
opt) = V (2). This is equivalent to test the intersection of the following two
hypotheses:
H
(j)
0 : V (d
opt,(j)) = max
k∈{0,1,2},k ̸=j
V (k),
for j = 0, 1, where dopt,(j) is the optimal treatment regime comparing Treatment 2 with
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Treatment j. For testing H
(j)
0 , we computed the test statistic T̂
dr,j
SRP as described in Section
3.3 and 4.1. We set B = 100000 and δn = log(log10(2n))/(2n)
1/6. For a given 0 < α < 1,
we reject H0 if
max
j=0,1
T̂ dr,jSRP > zα/4.
By Bonferroni’s inequality, the type-I error is well-controlled.
The two test statistics are equal to −0.67 and 0.31, respectively. We fail to reject H0
at a significance level of 0.1. Therefore, we suspect that the prognostic covariates in this
study might not have qualitative treatment effects. Zhao et al. (2012) performed pairwise
comparisons between the combination treatment and any single treatment, and estimate
the OITR by the outcome weighted learning. Their estimated optimal treatment regime
recommended the combination treatment to all the patients. Our tests formally verify their
findings.
6 Discussion
In this paper, we develop tests for overall qualitative treatment effects. The test statis-
tics are constructed by a sample-splitting method. In the high-dimensional setting, we
use sparse random projections of the covariate space to construct the test statistic and
introduce a data-dependent way to sample sparse projection matrices. In theory, we show
the consistency of the proposed test statistic and prove its “oracle” property in the regular
cases.
6.1 Multi-stage studies
Currently, we only consider a single stage study. For multiple-stage studies, it suffices to
test whether the value function under the optimal dynamic treatment regime is strictly
larger than those under nondynamic treatment regimes. Zhang et al. (2013) proposed
an inverse propensity-score weighted estimator for the value function under an arbitrary
dynamic treatment regime. Denoted by V̂DI(d1, d2) the corresponding estimator for the
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value difference between two dynamic treatment regimes d1 and d2, and dˆI the estimated
optimal dynamic treatment regime, based on the sub-dataset I. Consider the following
test statistic:
T̂CV = max
{
min
d∈Dnd
√|I2|V̂DI2(dˆI1 , d)
σˆI2(dˆI1 , d)
, min
d∈Dnd
√|I1|V̂DI1(dˆI2 , d)
σˆI1(dˆI2 , d)
}
,
where I1 and I2 stand for a random partition of the dataset, σˆ2I(d1, d2) some consistent
estimator for the asymptotic variance of
√|I|V̂DI(d1, d2) and Dnd denotes the set of non-
dynamic treatment regimes.
Note that for j = 1, 2, we have that under the null,
min
d∈Dnd
√|Ij|V̂DIj(dˆIcj , d)
σˆIj(dˆIcj , d)
≤ min
d∈Dnd
√|Ij|{V̂DIj(dˆIcj , d)− VD(dˆIcj , d)}
σˆIj(dˆIcj , d)
L→ min
d∈Dnd
Zd, (18)
where VD(d1, d2) = EV̂DI(d1, d2) and {Zd}d∈Dnd is a set of mean zero Gaussian random
variables whose covariance matrix can be consistently estimated from data. For a given
significance level α, we reject the null if T̂CV > cˆα/2 where cˆα corresponds to some consistent
estimator for Pr(mind∈Dnd Zd > zα). It follows from the Bonferroni’s inequality and (18)
that the type-I error of T̂CV is well-controlled. In the high-dimensional setting, we can
calculate T̂CV based on sparse random projections of the covariate space. Details are
omitted for brevity.
6.2 Choice of q
The choice of the projection dimension q involves a trade-off. If q is too large, then the
curse of dimensionality will affect the uniform convergence rates of τˆ
Sj
I in (A8), resulting
in decreased power of the corresponding test. If q is too small, then the OITR is not well
approximated. In Section 4, we set q = 1. In the supplementary article, we examine the
performance of the proposed test with difference choices of q. Results show that the optimal
choice of q depends on the number of covariates involved in the OITR and varies across
different simulation settings. We further propose a method that adaptively determines q.
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Detailed algorithm is given in Section E.2 of the supplementary article. In our simulations,
we find such adaptive method is no worse than any fixed choice of q and has nearly optimal
performance in some cases.
A Variance estimator in Section 3.3.1
Define αˆI to be the penalized logistic regression estimator based on {(Xi, Ai)}i∈I , θˆ0,I
and θˆ1,I to be the penalized linear regression estimators based on {(Xi, Yi)}i∈I,Ai=0 and
{(Xi, Yi)}i∈I,Ai=1 respectively. Denoted by Mα,I the support of αˆI , i.e, Mα,I = {j =
1, . . . , p : αˆI,j ̸= 0}. Similarly define Mθ0,I and Mθ1,I to be the supports of θˆ0,I and θˆ1,I
respectively. Let
πˆi =
exp(XTi αˆI)
1 + exp(XTi αˆI)
,
For any treatment regime d, we define
σˆ2DR,I(d) =
1
|I| − 1
∑
i∈I
κ2i −
1
|I|(|I| − 1)
(∑
i∈I
κi
)2
,
where
κi =
{(
1− Ai
1− πˆi −
Ai
πˆi
)
Yi −
(
1− Ai
1− πˆi − 1
)
XTi θˆ0,I +
(
Ai
πˆi
− 1
)
XTi θˆ1,I
}
{1− d(Xi)}
+ I¯T1
(
1
|I|
∑
i∈I
Xi
T
Mα,I
πˆi(1− πˆi)XiMα,I
)−1
XiMα,I(Ai − πˆi)
− I¯T2
(
1
|I|
∑
i∈I
(1− Ai)XiTMθ0,IXiMθ0,I
)−1
XiMθ0,I(1− Ai)(Yi −X
T
i θˆ0)
+ I¯T3
(
1
|I|
∑
i∈I
AiXi
T
Mθ0,I
XiMθ0,I
)−1
XiMθ0,IAi(Yi −X
T
i θˆ1),
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and I¯j =
∑
i∈I Ii,j/n where
Ii,1 =
{
πˆi(1− Ai)
1− πˆi {Yi −X
T
i θˆ0,I}+
Ai(1− πˆi)
πˆi
{Yi − θˆ1,I}
}
XiMα,I{1− d(Xi)},
Ii,2 =
(
1− Ai
1− πˆi − 1
)
XiMθ0,I{1− d(Xi)}, Ii,3 =
(
Ai
πˆi
− 1
)
XiMθ1,I{1− d(Xi)}.
B Technical conditions
(C1.) Assume there exists some positive constants γ and δ0 such that
Pr{0 < |τ(X)| ≤ t} = O(tγ),
where the big-O term is uniform in 0 < t < δ0.
(C2.) Assume τˆ satisfies
E|τˆI(X)− τ(X)|2 = o
(|I|−(2+γ)/(2+2γ)) as |I| → ∞,
where the little-o term is uniform in the training samples I.
Condition (C1) is closely related to the margin assumption (Tsybakov, 2004; Audibert
and Tsybakov, 2007) in the classification literature. It is often used to obtain sharp upper
bounds on the difference between the value function under dopt and that under an estimated
OITR (Qian and Murphy, 2011; Luedtke and van der Laan, 2016). The larger the structure
parameter γ in (C1), the sharper the upper bounds. When τ(X) has a bounded density
function near 0, (C1) holds with γ = 1. If there exists some δ0 > 0 such that |τ(X)| ≥ δ0
almost surely, then (C1) holds with γ = +∞.
Condition (C2) depends on the “structural” parameter γ in (C1) and the convergence
rates of the estimated contrast function. The larger the γ, the more likely (C2) holds.
When γ = 1, (C2) requires E|τˆI(X)− τ(X)|2 = o(|I|−3/4). The rates of convergence of the
estimated contrast function are available for most often used machine learning or statistical
methods, such as spline methods (Zhou et al., 1998), kernel ridge regression (Steinwart and
Christmann, 2008; Zhang et al., 2013) and random forests (Biau, 2012). In Section C.1
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of the Appendix, we show (C2) holds when τˆ is computed by some of the aforementioned
methods. Combining (C1) together with (C2) gives V (dˆI) = V (d
opt) + op(|I|−1/2).
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